Enovis CORPENOV決算レポート
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.
ENOV Q4 2025 Key Financial Metrics
売上高
$548.9M
粗利益
$328.9M
営業利益
$-558.5M
純利益
$-571.1M
粗利益率
59.9%
営業利益率
-101.7%
純利益率
-104.1%
前年比成長
-2.2%
EPS
$-9.99
資金フロー
Enovis CORP Q4 2025 財務サマリー
Enovis CORP reported revenue of $548.9M (down 2.2% YoY) for Q4 2025, with a net profit of $-571.1M (up 18.8% YoY) (-104.1% margin). Cost of goods sold was $220.0M, operating expenses totaled $887.4M.
主要財務指標
| 総売上高 | $548.9M |
|---|---|
| 純利益 | $-571.1M |
| 粗利益率 | 59.9% |
| 営業利益率 | -101.7% |
| 報告期間 | Q4 2025 |
売上内訳
Enovis CORP Q4 2025 revenue of $548.9M breaks down across 4 segments, led by Reconstructive Segment at $258.0M (47.0% of total).
| セグメント | 売上高 | 構成比 |
|---|---|---|
| Reconstructive Segment | $258.0M | 47.0% |
| Surgical | $129.0M | 23.5% |
| Prevention And Recovery | $92.6M | 16.9% |
| Other Prevention And Recovery | $71.4M | 13.0% |
Enovis CORP セグメント別売上 — 四半期推移
Enovis CORP revenue by segment across the last 4 reported quarters, showing how each business line (such as Reconstructive Segment and Surgical) has evolved quarter over quarter.
| セグメント | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|---|
| Reconstructive Segment | $258.0M | $274.0M | $286.3M | $274.0M |
| Surgical | $129.0M | — | — | — |
| Prevention And Recovery | $92.6M | $98.9M | $90.9M | $92.5M |
| Other Prevention And Recovery | $71.4M | $70.8M | $66.6M | $70.2M |
Enovis CORP 年度売上推移
Enovis CORP annual revenue history includes year-by-year totals (for example, 2024 revenue was $2.1B). Click any linked year to see what changed vs the prior 10-K.
Enovis CORP 四半期売上・純利益の履歴
Enovis CORP quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| 四半期 | 売上高 | 売上前年比 | 純利益 | 純利益率 |
|---|---|---|---|---|
| Q4 2025 | $548.9M | -2.2% | $-571.1M | -104.1% |
| Q3 2025 | $564.5M | +11.7% | $-36.7M | -6.5% |
| Q2 2025 | $558.8M | +6.4% | $-56.0M | -10.0% |
| Q4 2024 | $561.0M | +23.3% | $-703.2M | -125.4% |
| Q3 2024 | $505.2M | +21.0% | $-31.5M | -6.2% |
| Q2 2024 | $525.2M | +22.6% | $-18.6M | -3.5% |
| Q1 2024 | $516.3M | +27.1% | $-72.0M | -13.9% |
| Q4 2023 | $455.0M | +15.2% | $3.1M | 0.7% |
損益計算書
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $455.0M | $516.3M | $525.2M | $505.2M | $561.0M | $558.8M | $564.5M | $548.9M |
| 前年比成長 | 15.2% | 27.1% | 22.6% | 21.0% | 23.3% | 6.4% | 11.7% | -2.2% |
貸借対照表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $4.51B | $5.48B | $5.44B | $5.55B | $4.72B | $4.88B | $5.02B | $4.43B |
| 総負債 | $1.09B | $2.17B | $2.15B | $2.22B | $2.15B | $2.25B | $2.44B | $2.41B |
| 株主資本 | $3.42B | $3.31B | $3.29B | $3.33B | $2.56B | $2.62B | $2.58B | $2.02B |
キャッシュフロー
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $68.4M | $-36.2M | $7.8M | $53.6M | $88.3M | $-1.6M | $47.8M | $82.6M |